These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 10657459)

  • 21. Carcinoma of the prostate with metastases to the skin and glans penis.
    Oka M; Nakashima K
    Br J Urol; 1982 Feb; 54(1):61. PubMed ID: 7059760
    [No Abstract]   [Full Text] [Related]  

  • 22. Immunohistochemical expression of prostate specific antigen (PSA) in benign and malignant tumors of the prostate.
    Dema A; Tudose N
    Rom J Morphol Embryol; 1998; 44(1-4):93-100. PubMed ID: 15678849
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Breast metastasis from prostate cancer and interpretation of immunoreactivity to prostate-specific antigen.
    Cheng CW; Chan LW; Ng CF; Chan CK; Tse MK; Lai MM
    Int J Urol; 2006 Apr; 13(4):463-5. PubMed ID: 16734876
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Use of pleural fluid prostate specific antigen in the diagnosis of malignant effusion from metastatic prostate cancer.
    Go RS; Klee GG; Richardson RL
    J Urol; 2000 Aug; 164(2):459. PubMed ID: 10893618
    [No Abstract]   [Full Text] [Related]  

  • 25. Rare cutaneous manifestation of prostate cancer.
    Van Meter JR; Owen CE; Bahrami S; Callen JP
    Arch Dermatol; 2010 Feb; 146(2):206-8. PubMed ID: 20157042
    [No Abstract]   [Full Text] [Related]  

  • 26. [Cutaneous metastasis of prostatic cancer].
    Tejeda Báñez E; Argüello Valentín C; Romero Rodríguez F; Casanueva Luis T
    Arch Esp Urol; 1983; 36(3):217-20. PubMed ID: 6625697
    [No Abstract]   [Full Text] [Related]  

  • 27. Unusual prostate carcinoma characterized by extensive metastasis, significantly increased serum level of prostatic-specific antigen,and neuroendocrine differentiation: a case report.
    Hu YX; Ye J; Jiang Y; Zhang QF; Wu YL; Chen YY
    Chin Med J (Engl); 2005 Feb; 118(3):258-61. PubMed ID: 15740661
    [No Abstract]   [Full Text] [Related]  

  • 28. Violaceous plaque on the forehead clinically resembling angiosarcoma: cutaneous metastasis in a patient with prostatic adenocarcinoma.
    Boswell JS; Davis MD
    J Am Acad Dermatol; 2005 Oct; 53(4):744-5. PubMed ID: 16198815
    [No Abstract]   [Full Text] [Related]  

  • 29. The correlation of serial prostate specific antigen measurements with clinical outcome after external beam radiation therapy of patients for prostate carcinoma.
    Vollmer RT
    Cancer; 2001 Mar; 91(5):1063-5. PubMed ID: 11251961
    [No Abstract]   [Full Text] [Related]  

  • 30. Intracranial and scalp metastasis of endometrial carcinoma.
    Farooq MU; Chang HT
    Med Sci Monit; 2008 Sep; 14(9):CS87-8. PubMed ID: 18758422
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Papillary adenocarcinoma of the prostate: report of 4 cases].
    Miki J; Ikemoto I; Shimomura T; Kiyota H; Oisi Y; Kondo I; Madarame J; Endo K; Takahashi H
    Hinyokika Kiyo; 2003 Jan; 49(1):21-4. PubMed ID: 12629776
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Renal cell carcinoma presenting as a scalp swelling.
    Eke N; Eghwrudjakpor P; Echem RC
    Niger J Med; 2003; 12(3):154-6. PubMed ID: 14737987
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Sister Mary Joseph's nodule: recurrent endometrial adenocarcinoma presenting as an umbilical metastasis.
    Sengupta S; Church E; Chia KV
    J Obstet Gynaecol; 2009 Feb; 29(2):170-1. PubMed ID: 19274568
    [No Abstract]   [Full Text] [Related]  

  • 34. Immunophenotypic characterization of 225 prostate adenocarcinomas with intermediate or high Gleason scores.
    Goldstein NS
    Am J Clin Pathol; 2002 Mar; 117(3):471-7. PubMed ID: 11888088
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Prostatic antigen in pathologic anatomy].
    Varela Durán J
    Med Clin (Barc); 1992 Oct; 99(14):556-8. PubMed ID: 1279331
    [No Abstract]   [Full Text] [Related]  

  • 36. Prostatic remnants in mature cystic teratoma of the ovary.
    López JI; de Santamaría IS; Claros IJ; Garmendia M; Gaafar A; Bilbao FJ
    Ann Diagn Pathol; 2008 Oct; 12(5):378-80. PubMed ID: 18774505
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Free PSA forms in prostatic tissue and sera of prostate cancer patients: analysis by 2-DE and western blotting of immunopurified samples.
    Tabarés G; Jung K; Reiche J; Stephan C; Lein M; Peracaula R; de Llorens R; Hoesel W
    Clin Biochem; 2007 Mar; 40(5-6):343-50. PubMed ID: 17306785
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Violaceous exanthem as a manifestation of metastatic prostate cancer in skin.
    Slovin SF; Galsky MD; Busam K
    Urology; 2006 Feb; 67(2):420. PubMed ID: 16461102
    [No Abstract]   [Full Text] [Related]  

  • 39. Differential responsiveness of prostatic acid phosphatase and prostate-specific antigen mRNA to androgen in prostate cancer cells.
    Lin MF; Lee MS; Garcia-Arenas R; Lin FF
    Cell Biol Int; 2000; 24(10):681-9. PubMed ID: 11023645
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The role of P501S and PSA in the diagnosis of metastatic adenocarcinoma of the prostate.
    Sheridan T; Herawi M; Epstein JI; Illei PB
    Am J Surg Pathol; 2007 Sep; 31(9):1351-5. PubMed ID: 17721190
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.